HealthQuill Pharma
Malaria killed 1,157 people in Ethiopia during the first ten months of this year, and 7.3 million cases were reported in the landlocked East African nation — the highest number of annual cases recorded in the last seven years, according to the World Health Organization.
Climate Health Pharma

Malaria kills 1,157 people so far this year in Ethiopia, national risk ‘high’

Malaria killed 1,157 people in Ethiopia during the first ten months of this year, and 7.3 million cases were reported in the landlocked.

Read More
The EU faces a new set of healthcare challenges potentially more potent than the Covid-19 pandemic, and some states are “miles away” from ensuring efficient preventive environments, according to a report from the independent Globsec.
Drugs Health Pharma

EU faces new healthcare threats, some states ‘miles away’ from ready 

The EU faces a new set of healthcare challenges potentially more potent than the Covid-19 pandemic, and some states are “miles away” from.

Read More
Danish multinational pharmaceutical company Novo Nordisk’s end-stage trial in patients with fatty liver disease saw reduced liver scarring (fibrosis) and its resolution without worsening the condition.
Drugs Health Pharma

Novo Nordisk’s weight loss drug reduces liver scarring in end-stage trial

Danish multinational pharmaceutical company Novo Nordisk’s end-stage trial in patients with fatty liver disease saw reduced liver scarring (fibrosis) and its resolution without.

Read More
The World Health Organization has for the first time activated its emergency health network in eight countries affected by the mpox outbreak, including the worst-hit Democratic Republic of the Congo and Burundi.
Drugs Health Pharma

WHO activates emergency health network in mpox-hit nations for first time

The World Health Organization has for the first time activated its emergency health network in eight countries affected by the mpox outbreak, including.

Read More
Novartis AG, a global Switzerland-based pharmaceutical company, has agreed to pay Monte Rosa Therapeutics Inc., $150 million upfront to develop, manufacture and commercialise drug candidates, mainly in immunology.
Drugs Health Pharma

Novartis to pay Monte Rosa $150m upfront for MGD drug candidates

Novartis AG, a global Switzerland-based pharmaceutical company, has agreed to pay Monte Rosa Therapeutics Inc., $150 million upfront to develop, manufacture and commercialise.

Read More
AbbVie Inc. will acquire Aliada Therapeutics, a biotechnology company focused on developing drugs to treat diseases of the central nervous system such as Alzheimer’s disease, for $1.4 billion in cash.
Drugs Health Pharma

AbbVie to acquire Aliada for $1.4 billion, bags Alzheimer’s therapy 

AbbVie Inc. will acquire Aliada Therapeutics, a biotechnology company focused on developing drugs to treat diseases of the central nervous system such as.

Read More
AstraZeneca Plc’s drug Fasenra got approval from the European Union regulator for treating adult patients with a rare inflammation of blood vessels.
Drugs Health Pharma

AstraZeneca’s drug to treat rare blood vessel disease gets EU nod

AstraZeneca Plc’s drug Fasenra got approval from the European Union regulator for treating adult patients with a rare inflammation of blood vessels.

Read More
GSK Plc., will invest $800 million in its manufacturing facility in the US — the largest investment to date in the country — to make sterile liquid vaccines and medicines as demand grows.
Drugs Health Pharma

GSK to invest $800 million in US to double capacity at Marietta facility

GSK Plc., will invest $800 million in its manufacturing facility in the US — the largest investment to date in the country — to.

Read More
A clinical-stage US gene-editing company, Precision BioSciences, got approval from the Eastern European country of Moldova to start an in vivo human trial of a therapy to treat chronic hepatitis B.
Drugs Health Pharma

Moldova green lights Precision BioSciences human trial for HBV

A clinical-stage US gene-editing company, Precision BioSciences, got approval from the Eastern European country of Moldova to start an in vivo human trial.

Read More
Multiple US agencies are investigating an outbreak of E. coli in the country, which was reported after eating Quarter Pounders hamburgers at McDonald’s, as cases rise in new states.
Drugs Health Pharma

E.coli illness caused by McDonald’s Quarter Pounder rise in the US

Multiple US agencies are investigating an outbreak of E. coli in the country, which was reported after eating Quarter Pounders hamburgers at McDonald’s,.

Read More